MDS Virtual Congress 2021 Archives - Page 104 of 132

A Case of Autoimmune Orofacial Dyskinesia associated with Striational Antibody

K. Kyle, G. Crotty, N. Venna (Boston, USA)
A case of Bainbridge-Ropers syndrome in a child.

S. Kopishinskaia, A. Sitnikova, E. Parinova (Nizhny Novgorod, Russian Federation)
A case of dystonia-parkinsonism associated with a heterozygous PRKRA (DYT16) gene mutation

J. Wu, M. Christie, M. Schiess (Houston, USA)
A case of GAD ataxia and stiff leg syndrome

S. Kalampokini, A. Artemiadis, P. Zis, P. Bargiotas, G. Hadjigeorgiou (Nicosia, Cyprus)
A case of task-specific jaw tremor

YH. Lau, KM. Lau, JP. Joseph, AS. Mawardi (Kuala Lumpur, Malaysia)
A case of YY1-related isolated dystonia with severe oromandibular involvement

MJ. Malaquias, R. Rodrigues, J. Damásio, A. Mendes, J. Freixo, M. Magalhães (Porto, Portugal)
A cell-penetrating peptide (CPP) did not decrease 150-kDa BoNT/A toxin adsorption to surfaces or increase toxin potency or duration in a prototype formulation

D. Rupp, G. Nicholson, R. Briode, C. Nino, M. Do, J. Wan, L. Le, E. Vazquez-Cintron, C. Wu, M. Nelson, L. Steward, MF. Brin, A. Brideau-Andersen (Irvine, USA)
A Child with Fever-Induced Paroxysmal Weakness and Encephalopathy with ATP1A3 mutation

D. Ferman, Q. Luc (Los Angeles, USA)
A combined imaging based biomarker for Parkinson’s disease using diffusion kurtosis and quantitative susceptibility mapping

T. Welton, S. Hartono, S. Tan, YC. Shih, W. Lee, S. Chong, S. Ng, N. Chia, EK. Tan, L. Tan, LL. Chan (Singapore, Singapore)
A Computer-Vision Based Method for Quantifying Parkinsonian Gait

S. Rupprechter, G. Morinan, Y. Peng, J. O'Keeffe (London, United Kingdom)
A corneal nerve density possible progression biomarker in Parkinson’s disease (PD) patients: pilot study

S. Yaisawang, J. Sringean, N. Kasetsuwan, R. Bhiyasiri (Bangkok, Thailand)
A DIFFERENT RADIOLOGICAL PERSPECTIVE ON PARKINSON’S DISEASE AND PARKINSONISM: TRANSCRANIAL SONOGRAPHY

S. Eroglu Durmaz, O. Kursun, N. Oztekin, Y. Sucullu Karadag (Ankara, Turkey)
A direct longitudinal comparison of free water diffusion MRI and DaTscan SPECT in Parkinson’s Disease.

C. Conklin, D. Scott, L. Bracoud, J. Suhy (Princeton, USA)
A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)
A French national multicentric prospective study of the 1-year impact of STN-DBS on speech in Parkinson’s disease: profile of progression and prognostic factors.

T. Ollivier, S. Pinto, R. Viard, G. Kuchcinski, G. Touzet, L. Defebvre, D. Devos, C. Moreau (Lille, France)
A Machine Learning Approach to VTA Prediction in DBS

B. Hoenes, G. Steinke (Valencia, USA)
A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s disease leveraging the voice of the patient

S. Sardar, R. Bhatnagar, R. Badawy, J. Burton, V. Aggarwal, K. Romero, M. Minchik, M. Spott, D. Hill, J. Cosman, C. Lansdall, G. Stebbins, N. Zach, M. Frasier, T. Hastings, M. Javidnia, J. Duffen, H. Matthews, M. Lawton, D. Dexter, N. Ratcliffe, K. Fisher, L. Oliva, S. Jones, A. Dowling, M. Meinders, L. Evers, B. Bloem, J. Cedarbaum, M. Muller, D. Stephenson (Tucson, USA)
A Milestone-based approach to monitoring disease progression in Parkinson’s disease

M. Brumm, A. Siderowf, T. Simuni, C. Caspell-Garcia, L. Chahine, T. Foroud, V. Arnedo, A. Reimer, C. Tanner, K. Poston, D. Weintraub, S. Hutten, K. Kieburtz, K. Marek, C. Coffey (Iowa City, USA)
A National Data-Linkage Study of Incidence and Prevalence of Primary Dystonia

G. Bailey, A. Rawlings, W. Pickrell, K. Peall (Cardiff, United Kingdom)
A neurophysiological profile associated with impulse control disorders in Parkinson’s disease

E. Iglesias Camacho, JF. Martín-Rodríguez, I. Santiago García-Rayo, L. Garrote Espina, P. álvarez Toledo, P. Franco Rosado, S. Jesús, L. Muñoz Delgado, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, P. Mir (Sevilla, Spain)
A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson’s disease

C. Fevga, Y. Park, E. Lohmann, A J. Kievit, G J. Breedveld, F. Ferraro, L. de Boer, R. van Minkelen, H. Hanagasi, A. Boon, W. Wang, G A. Petsko, Q Q. Hoang, M. Emre, V. Bonifati (Rotterdam, Netherlands)
A new fully implantable Adaptive Deep Brain Stimulation system tested for the first time in patients with Parkinson’s Disease

T. Mandat, R. Eleopra, M. Lanotte, L. Lopiano, M. Yanssen, Y. Temel, E. Pirola, P. Rampini (Warsaw, Poland)
A new mutation in the C-terminal domain of the YY1 gene associated with Gabriele-de Vries syndrome.

J. Gamez, M. Garcia-Hoyos, O. de Fabregues (Sant Just Desvern, Spain)
A New Phase of the Parkinson’s Outcomes Project Registry Study

A. Naito, C. Marras, J. Beck, R. Deleon, M. Neault, N. Dahodwala, T. Davis, M. Rafferty, A. Ramirez-Zamora, S. Luo (Miami, USA)
A novel ANO3 variant associated with generalized dystonia in an elderly woman

A. Boddu, H. Williams, H. Walker (Birmingham, USA)
A novel GRM1 variant associated with autosomal dominant cerebellar ataxia (ADCA)

A. Boddu, D. Standaert (Birmingham, USA)
A novel tele-rehabilitation program aimed at reducing fall risk in Parkinson’s Disease patients

M. Afshari, A. Hernandez, C. Goetz, J. Joyce (Chicago, USA)
A novel variant [c.2974G>A; (p.Asp992Asp)] of DYT/PARK-ATP1A3

R. Baviera-Muñoz, M. Campins-Romeu, I. Sastre-Bataller, M. Losada-López, J. Pérez García, E. Novella-Maestre, I. Martinez-Torres (Valencia, Spain)
A Pandemic Care Partner Summit: Online Program Helps Parkinson’s Care Partners Take Positive Actions

D. Perret, A. Wallis (Miami, USA)
A perception of knowledge on Parkinson’s disease among University students

K. Gohain, M. Changmai (Shah Alam, Malaysia)
A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson’s Disease Dementia.

SH. Pasternak, C. Silviera, K. Coleman, E. Finger, J. Wells, M. Borrie, S. Morrow, G. Zou, R. Bartha, P. Macdonald, ME. Jenkins, M. Jog, R. Tirona, CA. Rupar (London, Canada)
A phase 2b randomized, double-blind, placebo-controlled study of suvecaltamide in the treatment of adults with moderate to severe essential tremor: study design and methodology

A. Sterkel, W. Ondo, R. Elble, P. Lewitt, R. Pahwa, C. Urrea, L. Huang, L. Hickey, M. Baladi (Palo Alto, USA)
A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

J. Jankovic, C. Comella, R. Hauser, A. Patel, T. Gross, R. Rubio, D. Vitarella (Houston, USA)
A phase IV, randomized, double-blind cross-over study comparing the clinical safety, efficacy and duration of abobotulinumtoxinA with onabotulinumtoxinA in adults with upper-limb spasticity: The DIRECTION study

A. Esquenazi, Z. Ayyoub, M. Verduzco-Gutierrez, P. Maisonobe, J. Otto, A. Patel (Elkins Park, USA)
A physical therapy of postural reeducation with a tilt table for a patient with Parkinson’s disease complicated with dropped head syndrome

K. Sato, E. Kitahara, K. Nishioka, N. Hattori, T. Fujiwara (Tokyo, Japan)
A prospective study of Parkinson’s disease dementia – defining neuropsychological features

E. Stefanova, LJ. Ziropadja, T. Stojkovic, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
A prospective study of Parkinson’s disease progression towards dementia – dynamics and defining motor features

T. Stojkovic, LJ. Ziropadja, E. Stefanova, V. Markovic, I. Stankovic, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)
A qualitative evaluation of the health-related quality of life impact on informal caregivers to patients with neurogenic orthostatic hypotension

K. Gallop, N. Pham, G. Maclaine, E. Saunders, B. Black, S. Acaster (London, United Kingdom)
A Rare Case of Reversible Acute Parkinsonism in Fulminant HIV Encephalopathy

E. Chew, PC. Teh, CK. Er, TK. Ng, Z. Abdul Wahab, S. Bazin (Seremban, Malaysia)
A real-life study of Medical Cannabis effect on adults with dystonia

S. Anis, A. Faust-Socher, D. Sverdlov, N. Hezi, N. Giladi, T. Gurevich (Tel Aviv, Israel)
A retrospective analysis of Movement Disorder Patient Referrals for Functional Neurosurgery in the Neurosciences Department of Mater Dei Hospital

M. Bonello, J. Aquilina (Pieta, Malta)
A retrospective review of clinical and MRI/CT radiological correlation in progressive supranuclear palsy (PSP)

T. Wongwarawipat, G. Shepherd, A. Chatterjee (Reading, United Kingdom)
A retrospective review of clinical features of Progressive Supranuclear Palsy (PSP) in a movement disorders clinic

G. Shepherd, T. Wongwarawipat, A. Chatterjee (Reading, United Kingdom)
A Review of Electronic Devices to Track Medication Adherence in Parkinson’s Disease

H. Bernstein, FE. Godkin, W. Mcilroy, K. van Ooteghem (Waterloo, Canada)
A screening tool to assess telehealth suitability among patients with Huntington’s disease

S. Lee, L. Hale, K. Mcdonell (Nashville, USA)
A single session of transcranial direct current stimulation improves the postural responses after external perturbations in both people with Parkinson’s disease fallers and non-fallers

G. Moraca, V. Beretta, D. Orcioli-Silva, M. Pereira, B. Legutke, R. Vitório, L. Gobbi (Rio Claro, Brazil)
A study of microstructural changes and functional connectivity in cranial, cervical, and cranio-cervical segmental dystonia by multimodal MRI

S. Agrawal, S. Kumaran, S. Pandey (New Delhi, India)
A unique variant of ocular palatal tremor and facial muscle twitches

M. Elkasaby, A. Alqahtani, F. Ghasia, A. Shaikh (Cleveland, USA)
A usability study of an exergame application for Parkinson’s disease

CL. Chung, WQ. Lee, JY. Voon, WL. Poh, ZR. Yee, YQ. Chua, ML. Tan, XM. Neo (Singapore, Singapore)
A young man with rapidly progressive spastic hemiplegia.

J. Abreu, C. Serrano, D. Reyes, B. Deliz, E. Labat (San Juan, Puerto Rico)
A53T-SNCA-BAC transgenic mouse exhibits multiple prodromal symptoms of Parkinson’s disease: Gastrointestinal dysfunction, hyposmia and RBD-like behavior.

T. Taguchi, M. Ikuno, H. Yamakado, R. Takahashi (Kyoto, Japan)
ABBV-0805, a novel α-synuclein oligomer selective antibody, prolonged lifespan and prevented accumulation of α-synuclein pathology in mouse models of Parkinson’s disease

J. Fälting, F. Eriksson, J. Sigvardson, M. Johannesson, A. Kasrayan, M. Jones-Kostalla, P. Appelkvist, L. Söderberg, M. Blom, A. Rachalski, K. Nordenankar, O. Zachrisson, E. Amandius, G. Osswald, M. Moge, M. Ingelsson, J. Bergström, L. Lannfelt, C. Möller, M. Giorgetti, E. Nordström (Stockholm, Sweden)
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)
Abnormalities of vestibular-evoked myogenic potentials are associated with REM sleep without atonia in early Parkinson’s disease and idiopathic REM sleep behavior disorder

XIE. Wei Ye, S. Yun, Z. Sheng, C. Jing, MAO. Cheng Jie, DAI. Yong Ping, LIU. Chun Feng (Suzhou, China)
Absence of neutralizing antibody formation during incobotulinumtoxinA treatment of spasticity in botulinum toxin-naïve children with cerebral palsy: pooled analysis of Phase 3 studies

H. Chambers, P. Kaňovský, A. Schroeder, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M. Banach, D. Gaebler-Spira, F. Heinen (San Diego, USA)
Accelerometry to optimize optical flow measurement of repetitive finger tapping movements: A pilot study

K. Zumaeta, E. Torres, L. Urdiales, A. Ramirez, I. Camargo, B. Castaneda, S. Romero, K. Lizarraga (Lima, Peru)
Accuracy in Detection of Performance of Activities of Daily Living in Subjects with Parkinson’s Disease by Using Inertial Sensors and Decision Tree Classifiers

AI. Perez Sanpablo, J. Quinzanos-Fresnedo, C. Hernandez Arenas, A. Meneses-Penaloza, A. Gonzalez-Mendoza, JC. Castro Padilla, I. Quinones-Uriostegui, V. Bueyes-Roiz, Y. Quijano-Gonzalez, A. Alessi-Montero (Mexico City, Mexico)
Accuracy of Frontal Assessment Battery to detect Mild Cognitive Impairment in a Cuban sample of Parkinson’s disease patients

Y. Broche-Pérez, E. Jiménez-Puig, Z. Fernández-Fleites, S. Morales-Ortiz, LR. Crespo-Rodríguez (Santa Clara, Cuba)
Acute cerebellar ataxia as a possible post-COVID-19 manifestation – case report

B. Ciopleiaș, R. Makk, M. Chioașcă, D. Rusu, ș. Diaconu, L. Irincu, C. Falup-Pecurariu (Brasov, Romania)
Acute functional movement disorder in a Lupus patient

D. Rebolledo, J. Diestel, I. Reyes (Mexico City, Mexico)
Acute Onset, Unilateral Restless Leg Syndrome after Subthalamic Nucleus Deep Brain Stimulation

M. Bock, R. Zuzuarregui (San Francisco, USA)
Adding environmental context to passive wearable sensor data

D. Hill, T. Tran, T. Le, N. Defranoux, A. Devaux, A. Castillejo, V. Janousek (Grenoble, France)
Adherence to medication among Serbian Parkinson’s disease patients: a cross-sectional study

A. Milovanović, B. Radojević, NT. Dragašević-Mišković, M. Svetel, I. Petrović, A. Tomić-Pešić, M. Savić, D. Stanisavljević, VS. Kostić (Belgrade, Serbia)
Adopting a low-cost multidisciplinary telemedicine approach for falls prevention in Parkinson´s Disease.

A. García-Bustillo, JM. Ramírez-Sanz, JL. Garrido-Labrador, A. Arnaiz-González, F. Valiñas-Sieiro, M. Allende-Río, JJ. González-Bernal, J. González-Santos, JF. Díez-Pastor, M. Jahouh, JM. Trejo-Gabriel-Galán, E. Cubo (Burgos, Spain)
ADROIT study: current recruitment and DBS implant data

S. Groppa, J. Pilitsis, S-Y. Shin-Yuan, J. Vesper, L. Verhagen, Y. Bezchlibnyk, M. Navas Garcia, K. Ashkan, S. Nagel, R. Pahwa, C. Giordana, A. Lehn, T. Warnecke, M. Glaser, S. Lin, F. Defresne, E. Karst, B. Cheeran, A. Schnitzler (Mainz, Germany)
Advocacy for Neuropalliative Care in Parkinson Disease Care: The Need for an International Neuropalliative Care Society (INPCS)

U. Ramanathan, C. Chou, E. Richfield, D. Oliver, C. Creutzfeldt, B. Kluger (Toronto, Canada)
Age-dependent multisystem parkinsonian features in a novel neuromelanin-producing transgenic mouse model

N. Peñuelas, A. Laguna, M. Gonzalez-Sepulveda, LL. Miquel-Rio, N. Benseny-Cases, H. Xicoy, J. Compte, A. Nicolau, M. Lorente-Picón, E. álvarez-Marimon, J. Romero-Giménez, A. Parent, T. Cuadros, F. Cacho-Nerin, J. Cladera, A. Bortolozzi, I. Carballo-Carbajal, M. Vila (Barcelona, Spain)
Akinetic-rigid motor presentation among adult-onset HD participants in Enroll-HD

A. Vishnu, M. Guttman, C. Mariotti, J. Corey-Bloom, L. Jones, F. Walker, K. Marder, S. Kwak, K. Becanovic, N. Ghosh, S. Sathe, C. Sampaio (White Plains, USA)
Alpha-synuclein oligomers detection by proximity ligation assay in skin biopsy is a biomarker for Parkinson’s disease

E. Vacchi, C. Senese, S. Pinton, A. Kaelin-Lang, G. Melli (Lugano, Switzerland)
Alteration of lysosomal enzymatic activities in patients with multiple system atrophy

A. Bezrukova, K. Basharova, D. Bogdanova, K. Senkevich, A. Zhuravlev, E. Gracheva, I. Miliukhina, G. Baydakova, E. Zakharova, A. Emelyanov, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Alterations in brain functional network connectivity in Parkinson’s disease patients with MCI

K. Sreenivasan, X. Zhuang, J. Caldwell, A. Ritter, D. Cordes, Z. Mari, V. Mishra (Las Vegas, USA)
Altered functional activity of the motor system related to ankle and hand movements in Parkinson’s disease: insights from functional MRI

T. Gauss, I. Malik, J. Martello, C. Knight, J. Jeka, R. Burciu (Newark, USA)
Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease

D. Pourzinal, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, K. Mcmahon, D. Copland, N. Dissanayaka (Herston, Australia)
Altered glymphatic function in Parkinson’s disease

N. Ryoo, YJ. Bae, YS. Song, JM. Kim (Seongnam-Si, Republic of Korea)
Altered neuroplasticity in patients with functional movement disorders.

B. Demartini, F. Bianchi, A. D'Arrigo, T. Bocci, O. Gambini, L. Campiglio, A. Priori (Milano, Italy)
Altered Resting-state Neural Activity in Parkinson’s Disease with Depression: a controlled study based on original meta-analysis results

D. Su, Y. Cheng, J. Zhou, T. Feng (Beijing, China)
Alternative Medications for Paroxysmal Kinesigenic Dyskinesia

T. Larsh (Cleveland, USA)
Amantadine DR/ER Efficacy as Early Add-On for Motor Complications in Parkinson’s Disease

C. Tanner, J. Lytle, A. Formella (San Francisco, USA)
Amantadine DR/ER-Related Reduction in OFF and Dyskinesia Improved Patient-Rated Interference with Activities and Social Interactions

K. Lyons, R. Pahwa, N. Crouse, L. Llorens, R. Howard, A. Formella (Kansas City, USA)
AMP PD: Collaborating in the discovery of biomarkers to accelerate the development of therapies for Parkinson’s disease

C. Swanson-Fischer, E. Appelmans, D. Babcock, M. Bookman, D. Alonso, L. Kirsch, C. Wonders, J. Ward, S. Biswas, S. Dey, A. Singleton, H. Iwaki (North Bethesda, USA)
Amyotrophic Lateral Sclerosis with SOD1 mutation presenting with progressive cerebellar ataxia

M. Sequeira, P. Faustino, J. Lourenço (Lisboa, Portugal)
An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series

D. Lux, L. Wu, H. Ling, T. Warner, A. Lees, T. Revesz, Z. Jaunmuktane, J. Rohrer, H. Morris (London, United Kingdom)
An Eye of a Tiger cannot see all the true: a case series.

I. Teixeira, S. Trivellato, I. Fonseca, D. Margato, R. Bazan, A. Schelp (Botucatu, Brazil)
An Eyes-Open/Closed Manipulation Reveals Disrupted Default Mode Network Connectivity in Parkinson’s Disease and REM Sleep Behavior Disorder

T. Ellmore, J. Suescun, S. Chandra, V. Thyne, M. Schiess (New York, USA)
An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD

O. Ojo, JH. Ahn, Z. Aldaajani, J. Bajwa, A. Bustillo, A. Cardozo, M. Dekker, E. Eldayem, Z. Mari, A. Shalash, M. Shackleford, M. Spindler, J. Youn, E. Cubo, N. Okubadejo (Idi-Araba, Nigeria)
An unusual case of belly dancer´s dyskinesia in a man with Huntington disease

S. Rodriguez Navas, E. García Roldán, D. Macías-García, A. Vilches Guerra, FJ. Palomar-Simón, F. Carrillo, M. Ruiz-Veguilla, P. Mir (Sevilla, Spain)
An Unusual Case of Multiple Systems Atrophy with Long Disease Duration, Severe Gliosis, and Scant Synuclein Pathology

D. Coughlin, I. Dryden, B. Wright, S. Lessig, D. Galasko, A. Hiniker (San Diego, USA)
Analysis of Amantadine formulations for OFF and Dyskinesia in Parkinson Disease

W. Oertel, R. Pahwa, R. Hauser, M. Sale, G. Went (Marburg, Germany)
Analysis of brain structural connectivity networks and white matter integrity in patients with early Parkinson’s disease: a longitudinal study

R. Walsh, M. Bergamino, A. Stokes (Phoenix, USA)
Analysis of dystonia and rating scales in children and young adults with SGCE myoclonus dystonia

M. Correa-Vela, J. Carvalho, M. Vanegas, A. Cazurro-Gutiérrez, V. González, R. Alvárez, A. Marcé-Grau, A. Moreno, A. Macaya, B. Pérez-Dueñas (Barcelona, Spain)
Analysis of effectiveness of Montreal Cognitive Assessment as cognitive evaluation method in low education level patients with Parkinson’s disease in the Brazilian Amazon.

B. Koshimoto, A. Escudeiro, R. Feio, D. Moura, M. Montenegro, A. Silva, B. Lobato (Belém, Brazil)
Analysis of handgrip strength, upper limb traction and ground reaction force on bus step climb in healthy elderly subjects and individuals with Parkinson’s disease

A. Miri, H. Gonçalves Araújo, A. Gil, E. Angelo, R. Volpe, B. Masson, A. da Silva, S. Smaili (Londrina, Brazil)
Analysis of Sleep Structure and EEG Characteristics of Patients with Dyskinesia in Parkinson’s Disease

YM. Wang, CJ. Mao (Soochow, China)
Analysis of the correlation between the raphe nucleus echo and neurological diseases with depression/anxiety.

YAN. Shao, YI. Liu (Dalian, China)
Analysis of the HLA locus in isolated REM sleep behavior disorder and Lewy body dementia

E. Yu, L. Krohn, J. Ruskey, F. Asayesh, S. Laurent, D. Spiegelman, Z. Shah, I. Arnulf, M. Hu, J. Montplaisir, JF. Gagnon, A. Desautels, Y. Dauvilliers, G. Gigli, M. Valente, F. Janes, A. Bernardini, B. Högl, A. Stefani, A. Ibrahim, K. Sonka, D. Kemlink, W. Oertel, A. Janzen, G. Plazzi, E. Antelmi, M. Figorilli, M. Puligheddu, B. Mollenhauer, C. Trenkwalder, F. Sixel-Döring, V. Cochen, C. Monaca, A. Heidbreder, L. Ferini-Strambi, F. Dijkstra, M. Viaene, B. Abril, B. Boeve, G. Rouleau, R. Postuma, S. Scholz, Z. Gan-Or (Montreal, Canada)
Anodic prepulses influence the therapeutic window in ET patients

A. Boogers, J. Peeters, W. Vandenberghe, B. Nuttin, M. Mc Laughlin (Leuven, Belgium)
Anodic stimulation reduces corticospinal tract engagement in STN-DBS for Parkinson’s disease: a case report.

G. Di Rauso, S. Coniglio, A E. Vaudano, F. Cavallieri, A. Puzzolante, A. Feletti, F. Antonelli, S. Meletti, F. Valzania, V. Rispoli (Modena, Italy)
Antioxidants in foods: A Primary Potential remedy to Neurodegeneration.

B. Adebisi (Osogbo, Nigeria)
Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy.

O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, I. Buzaev, A. Saveliev, N. Mukhamadeeva, G. Akhmadeeva (Ufa, Russian Federation)
Apathy Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial

T. Stiep, A. Ramirez-Zamora, A. Tröster, R. Jain, L. Chen, M. Okun (Gainesville, USA)
Apathy: an underestimated feature in premotor period of GBA and LRRK2 non-manifesting mutation carriers.

I. Pachi, C. Koros, A. Simitsi, D. Papadimitriou, A. Bougea, A. Prentakis, N. Papagiannakis, M. Bozi, R. Antonelou, E. Angelopoulou, I. Beratis, M. Stamelou, X. Trapali, S. Papageorgiou, L. Stefanis (Athens, Greece)
Apomorphine infusion before subthalamic deep brain stimulation. A prospective comparative study in the same 20 patients.

G. Fernández-Pajarín, A. Sesar, B. Ares, I. Jimenez-Martín, M. Gelabert-González, E. Arán-Echabe, JL. Relova, A. Castro (Santiago de Compostela, Spain)
Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Analysis of Baseline Factors

A. Nicholas, C. Singer, I. Zhang, E. Pappert, B. Navia (Birmingham, USA)
Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Characterization of Acute Nausea During Dose Titration

W. Ondo, R. Hauser, A. Bowling, S. Isaacson, E. Pappert, B. Navia (Houston, USA)
Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting

R. Hauser, S. Factor, W. Ondo, I. Zhang, E. Pappert, B. Navia (Tampa, USA)
Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact on Dyskinesia

K. Klos, J. Hui, I. Zhang, E. Pappert, B. Navia (Tulsa, USA)
Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact on Impulse Control Disorders

A. Espay, K. Markopoulou, I. Zhang, E. Pappert, B. Navia (Cincinnati, USA)
Application of the updated MDS criteria for prodromal Parkinson’s disease to a population-based 10-year study

K. Marini, K. Seppi, L. Tschiderer, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)
Approaching the lateral pterygoid muscle in botulinum toxin injections. How to avoid the maxillary artery

S. Unal, T. Karaarslan-Turk, C. Akbostanci, E. Peker, R. Yilmaz (Ankara, Turkey)
Are Mobile Persons with Parkinson Disease Necessarily More Active?

J. Zajac, J. Cavanaugh, T. Baker, C. Colón-Semenza, T. Deangelis, R. Duncan, D. Fulford, M. Lavalley, T. Nordahl, K. Rawson, M. Saint-Hilaire, C. Thomas, G. Earhart, T. Ellis (Boston, USA)
Are physiotherapists reliable in their scoring of freezing of gait?

A. Scully, K. Neo, E. Lim, D. Tan (Bentley, Australia)
Are we addressing the emotional burden? – recognition of mood disorders in patients with essential tremor

G. Douglas, A. Doyle, S. Rafee, S. O'Riordan (Dublin, Ireland)
Arm swing instructions alter interlimb coordination but not prefrontal cortex activity of Parkinson’s disease persons.

V. Zampier, L. Mochizuki, D. Silva, V. Beretta, V. Belli, L. Gobbi (Rio Claro, Brazil)
Assessing effectiveness of abobotulinumtoxinA injections for adult lower limb spasticity in routine clinical practice: The ongoing AboLiSh study

A. Esquenazi, R. Zorowitz, S. Ashford, F. Calvi-Gries, P. Maisonobe, S. Page, J. Jacinto (Elkins Park, USA)
Assessment of Fluctuating Parkinson’s Disease with Sensor-Based Home Monitoring-Feasibility Results

T. Fay-Karmon, N. Galor, B. Heimler, R. Bartsch, A. Zilka, V. Livneh, M. Plotnik, S. Hassin-Baer (Ramat Gan, Israel)
Association between adverse childhood experiences and functional seizures among FND patients in the FND Patient Registry

B. Mildon, E. Snow, J. Occean, N. Agu, A. Salinas-Miranda (Salmon, USA)
Association between Alzheimer’s disease co-pathology and neuropsychiatric symptoms in Lewy body dementia

J. Dipane, D. Coughlin, E. Bayram (La Jolla, USA)
Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)
Association between Hippocampal Subfields, CSF Biomarkers, and Cognition in non-demented Parkinson’s patients

S. Becker, O. Granert, M. Timmers, A. Pilotto, L. van Nueten, B. Roeben, G. Salvadore, W. Galpern, J. Streffer, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)
ASSOCIATION BETWEEN INSULIN RESISTANCE AND DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON´S DISEASE

C. Borrue-Fernandez, E. Ferriz (San Sebastian Reyes, Spain)
Association of presynaptic dopaminergic denervation with therapeutic effects of globus pallidus deep brain stimulation on freezing of gait in advanced Parkinson’s disease

SH. Lee, MS. Kim, YS. Hwang, SY. Jo, SR. Jeon, SJ. Chung (Seoul, Republic of Korea)
Associations between Baseline Cognitive Function and Gait Outcomes after Treadmill Training in Parkinson’s disease

R. Amin, J. Phillips, A. Humbert, B. Cholerton, C. Zabetian, I. Mata, V. Kelly (Seattle, USA)
Associations between Exercise Classes and Self-Reported Exercise by People with Parkinson’s Disease at Parkinson’s Foundation Centers of Excellence

E. Nettnin, S. Burrows, D. Simon, S. Wu, G. Miao, M. Rafferty (Chicago, USA)
Ataxia in a Puerto Rican woman with a missense variant in the CCDC88 gene

C. Serrano, J. Abreu, J. Otero (San Juan, Puerto Rico)
Attitudes on therapy-associated risks in individuals with multiple system atrophy and Parkinson’s disease and their views on aspects of clinical trials

AM. Bernhardt, T. Barthel, I. Friedrich, E. Kocakavuk, E. Nachman, M. Oeller, K. Peikert, M. Roderigo, A. Rossmann, LO. Wilhelm, M. Brandt, J. Classen, BH. Falkenburger, A. Frank, L. Hoegner, H. Jacobi, A. Janzen, S. Katzdobler, J. Nieweler, T. Prell, JJ. Rumpf, C. van Riesen, T. Warnecke, M. Weiler, F. Gandor, J. Levin, A. Giese, WH. Oertel (Munich, Germany)
Attitudes towards risk disclosure in prodromal Parkinson’s disease. Is there a cultural difference?

G. Kayis, R. Yilmaz, G. Yalcin-Cakmakli, B. Arda, B. Elibol, MC. Akbostanci (Ankara, Turkey)
Atypical gait in a patient with Huntington’s Disease (HD): Functional movement disorders in the spectrum of motor phenotypes in HD

H. Leal Bailey, K. Block, E. Furr-Stimming, S. Chandra (Houston, USA)
Atypical hemifacial spasm caused by an epidermoid cyst of the cerebellopontine angle

J. Rosa, S. Dias, M. Dias (Lisbon, Portugal)
Atypical presentation of Ataxia telangiectasia masquerading as Parkinson’s Disease

G. Casinelli, R. Tripathi (Morgantown, USA)
Autoimmunity may contribute to peri-electrode edema after deep brain stimulation for Parkinson’s disease: a case series

AD. Magalhães, L. Kauppila, P. Lobo, L. Guedes, M. Rosa, H. Carvalho, B. Cattoni, M. Coelho (Lisboa, Portugal)
Automated analysis of pen-on-paper spirals for tremor detection, quantification and differentiation

R. Rajan, R. Anandapadmanabhan, VY. Vishnu, A. Gupta, R. Bhatia, MB. Singh, AK. Srivastava, MVP. Srivastava (New Delhi, India)
Automated Mechanical Peripheral Stimulation for walking rehabilitation in Parkinson’s disease: a systematic review

T. Corbet, SN. Edd (Epalinges, Switzerland)
Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

M. Peres, G. Leroy, A. Gerhard, M. Hu, J. Klein, P. Leigh, A. Church, D. Burn, H. Morris, J. Rowe, T. Rittman (Cambridge, United Kingdom)
Automatic and objective speech analysis in Huntington disease

J. Adams, E. Dorsey, M. Coffey, M. Pawlik, C. Tarolli, R. Schneider, B. Najafi, H. Zhou, A. Vaziri, H. Nguyen (Rochester, USA)
Automatic Estimation of MDS-UPDRS Gait Scores from Videos with Multi-Rater Disagreements

E. Adeli, E. Sullivan, M. Lu, Q. Zhao, L. Montaser Kouhsari, M. Katz, A. Pfefferbaum, K. Pohl, V. Henderson, K. Poston (Stanford, USA)
Autonomic dysfunction in patients with Parkinson’s disease

B. Douma, I. Bedoui, M. Elfekih, H. Derbali, M. Messelmani, A. Riahi, M. Mansour, J. Zaouali, R. Mrissa (Sousse, Tunisia)
Autonomic Symptoms as Predictors of Quality of Life in Parkinson’s Disease: A 5-year follow up study

A. Bougea, S. Pantinaki, A. Antonoglou, P. Giannaki, F. Efthymiopoulou (Athens, Greece)
Autosomal recessive spinocerebellar ataxia type 10: a case report in Mexico

D. Gasca Saldaña, D. Dávila Ortiz, N. Monroy Jaramillo, C. Aláez-Verson, L. Flores-Lagunes, P. Zamora Alaniz, C. Dehesa Caballero, C. Fresno Rodríguez, G. Vega-Rosas, M. Boll (Mexico City, Mexico)
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: a Surgicogenomic Approach

N. Visanji, M. Ghani, E. Yu, E. Kakhki, C. Sato, D. Moreno, T. Naranian, YY. Poon, M. Abdollahi, M. Naghibzadeh, R. Rajalingam, A. Lozano, S. Kalia, M. Hodaie, M. Cohn, M. Statucka, A. Boutet, G. Elias, J. Germann, R. Munhoz, A. Lang, Z. Gan-Or, E. Rogaeva, A. Fasano (Toronto, Canada)
Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II clinical trial

J. Greenland, E. Cutting, S. Kadyan, S. Bond, A. Chhabra, C. Williams-Gray (Cambridge, United Kingdom)